Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: Result from a crossover study.
Phase of Trial: Phase III
Latest Information Update: 12 May 2011
At a glance
- Drugs Atorvastatin (Primary) ; Bezafibrate (Primary)
- Indications Hyperlipoproteinaemia type III
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.